Skip to main content
SpringerLink
Log in

Optimal follow-up of cervical cancer patients

  • short review
  • Published:
memo - Magazine of European Medical Oncology Aims and scope Submit manuscript

Abstract

Gynecological malignancies account for round 10 % of all female cancers, with the cervical cancer being one of the major women health problems in developing regions of the world. Surveillance programs of cervical cancer are primarily based on recurrence rates, timing of recurrence, salvage options, and chances for curing patients with recurrence. Since there is no prospective, high evidence data about optimal surveillance program after primary treatment of patients with cervical cancer recommendations are based on the review of retrospective data sets. Literature search on this topic showed that there is no proven survival benefit for any follow-up schedule. Counseling the patients about early possible signs and symptoms of recurrent disease is of great importance. From all the diagnostic tools available, history taking and clinical examination, including comprehensive gynecological examination, still contribute to the greatest number of recurrence detection. Chest radiograph and computed tomography of abdomen and pelvis could be done in high-risk patients taking into account initial stage of the disease, previous treatment, symptom status, and local findings in order to detect potentially salvageable recurrences. Otherwise, radiologic tests are usually employed when a suspicion of recurrence is raised. Follow-up plan should be tailored according to estimated risk of relapse for individual patient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lanceley A, Fiander A, McCormack M, Bryant A. Follow-up protocols for women with cervical cancer after primary treatment. Cochrane Database Syst Rev 2013;(11). Art. No.:CD008767. doi:10.1002/14651858.CD008767.pub2.

  2. American Cancer Society: cancer facts and figures 2014. Atlanta, Ga: American Cancer Society; 2014.

  3. Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol. 1999;17(5):1339–48.

    CAS  PubMed  Google Scholar 

  4. Peters WA, Liu PY, Barret RJ 2nd, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18(8):1606–13.

    CAS  PubMed  Google Scholar 

  5. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999;340(15):1137–43.

    Article  CAS  PubMed  Google Scholar 

  6. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340(15):1144–53.

    Article  CAS  PubMed  Google Scholar 

  7. Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 1999;340(15):1154–61.

    Article  CAS  PubMed  Google Scholar 

  8. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix and endometrium. Int J Gynaecol Obstet. 2009;105:103–4.

    Article  PubMed  Google Scholar 

  9. Arnold M, Liu L, Kentner GG, Creutzberg CL, Coebergh JW, Soerjomataram I. Second primary cancers in survivors of cervical cancer in Netherlands: implications for prevention and surveillance. Radiother Oncol. 2014. http://dx.doi.org/10.1016/j.radonc.2014.04.11. Accessed 1 Aug 2014.

  10. Elit L, Fyles AW, Devries MC, Oliver TK, Fung-Kee-Fung M. Follow-up for women after treatment for cervical cancer: a systematic review. Gynecol Oncol. 2009;114:528–35.

    Article  PubMed  Google Scholar 

  11. Mangler M, Lanowska M, Kohler C, Vercellino F, Schneider A, Speiser D. Pattern of cancer recurrence in 320 patients after radical vaginal trachelectomy. Int J Gynecol Cancer. 2014;29(1):130–4.

    Article  Google Scholar 

  12. Tanaka S, Nagase S, Kaiho-Sakuma M, et al. Clinical outcome of pelvic exenteration in patients with advanced or recurrent uterine cervical cancer. Int J Clin Oncol. 2014;19:133–8.

    Article  PubMed  Google Scholar 

  13. Mabuchi S, Isohashi F, Maruoka S, et al. Post-treatment follow-up procedures in cervical cancer patients previously treated with radiotherapy. Arch Gynecol Obstet. 2012;286:179–85.

    Article  PubMed  Google Scholar 

  14. Sartori E, Passinetti B, Carrara L, Gambino A, Odicino F, Pecorelli S. Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients. Gynecol Oncol. 2007;107:S241–7.

    Article  CAS  PubMed  Google Scholar 

  15. Bodurka-Bevers D, Morris M, Eifel PJ, et al. Posttherapy surveillance of women with cervical cancer: an outcome analysis. Gynecol Oncol. 2000;78:187–93.

    Article  CAS  PubMed  Google Scholar 

  16. Soisson AP, Geszler G, Soper JT, et al. A comparison of symptomatology, physical examination, and vaginal cytology in detection of recurrent cervical carcinoma after radical hysterectomy. Obstet Gynecol. 1990;76:106–9.

    CAS  PubMed  Google Scholar 

  17. Salani R, Backes FJ, Fung Kee Fung M. Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations. Am J Obstet Gynecol. 2011;204(6): 466–78.

  18. Samlal RA, Van Der Velden J, Van Eerden T, Schilthuis MS, Gonzalez Gonzalez D, Lammes FB. Reccurent cervical carcinoma after radical hysterectomy: an analysis of clinical aspects and prognosis. Int J Gynecol Cancer. 1998;8:78–84.

    Article  PubMed  Google Scholar 

  19. Lim KC, Howells RE, Evans AS. The role of clinical follow up in early stage cervical cancer in South Wales. BJOG: Int J Obstet Gynaecol. 2004;111(2):1444–8.

    Article  CAS  Google Scholar 

  20. Kim SH, Han MC. Invasion of the urinary bladder by uterine cervical carcinoma: evaluation with MR imaging. AJR Am J Roentgenol. 1997;168:393–7.

    Article  CAS  PubMed  Google Scholar 

  21. Havrilesky LJ, Kulasingam SL, Matchar DB, et al. FDG-PET for management of cervical and ovarian cancer. Gynecol Oncol. 2005;97:183–91.

    Article  PubMed  Google Scholar 

  22. Auguste P, Barton P, Meads C, et al. Evaluating PET-CT in routine surveillance and follow-up after treatment for cervical cancer: a cost-effectiveness analysis. BJOG. 2014;121:464–76.

    Article  CAS  PubMed  Google Scholar 

  23. Colombo N, Carinelli S, Colombo A, Marini C, Rollo D, Sessa C. Cervical cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23:vi27–32.

    Google Scholar 

  24. ESGO. Algorithms for management of cervical cancer. www.esgo.org/Education/Documents/Algorithms%20english%20version.pdf. Accessed 16 Jan 2015.

Download references

Author information

Authors and Affiliations

  1. Clinic for Oncology and Radiotherapy, Clinical Hospital Centre Split, Spinčićeva 1, 21 000, Split, Croatia

    Eduard Vrdoljak MD, PhD, Tihana Boraska Jelavić MD, PhD, Branka Petrić Miše MD, PhD & Tomislav Omrčen MD, PhD

Authors
  1. Eduard Vrdoljak MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tihana Boraska Jelavić MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Branka Petrić Miše MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Tomislav Omrčen MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eduard Vrdoljak MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vrdoljak, E., Boraska Jelavić, T., Petrić Miše, B. et al. Optimal follow-up of cervical cancer patients. memo 8, 66–70 (2015). https://doi.org/10.1007/s12254-015-0203-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12254-015-0203-y

Keywords

Search

Navigation